Related Experiment Video
Updated: Aug 4, 2025

11:11
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
4.6K
Challenges in Use of Practice-based Research Networks for a Medical Device Trial to Detect SARS-CoV-2
Jeanette M Daly1, Laurel O'Connor2, Megan E Schmidt3
1Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Journal of Primary Care & Community Health
|April 3, 2023
Summary
Primary care practice-based research networks (PBRNs) faced challenges in a SARS-CoV-2 point-of-care (POC) device study, including personnel, changing criteria, and equipment access. Future studies require better preparation for PBRN collaborations.
Area of Science:
- Clinical Research
- Public Health
- Biotechnology
Background:
- Primary care practice-based research networks (PBRNs) are crucial for real-world clinical research.
- Point-of-care (POC) diagnostic devices accelerate disease detection and management.
- The National Institutes of Health (NIH) funded a study to advance POC SARS-CoV-2 testing.
Purpose of the Study:
- To characterize participating PBRNs and collaborators in a SARS-CoV-2 POC device trial.
- To identify and describe challenges encountered during the execution of the device study within PBRNs.
Main Methods:
- Semi-structured interviews were conducted with key personnel from participating PBRNs and the lead academic institution (UMass Chan Medical School).
Main Results:
- Three out of four invited PBRNs participated, alongside UMass.
- The trial enrolled 321 subjects in six months, with PBRNs contributing 65 subjects.
- Key challenges included insufficient clinic personnel, evolving inclusion/exclusion criteria, data collection platform issues, and lack of specialized equipment (e.g., -80°C freezer).
Conclusions:
- PBRN participation in device studies is resource-intensive and faces significant operational hurdles.
- Future device studies should proactively address potential recruitment criterion changes, equipment needs, and study continuity to better support PBRN practices.
Related Concept Videos
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K

